Prognostic Index of Park et al for Advanced Biliary Tract Adenocarcinoma

Purpose: To evaluate a patient with advanced biliary tract adenocarcinoma using the prognostic index of Park et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with an advanced biliary tract adenocarcinoma?

Yes

Is the primary tumor an intrahepatic cholangiocarcinoma?

Yes

Serum alkaline phosphatase

Select an appropriate answer for each finding

Metastases

ECOG performance status

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Prognostic index (PI)

Risk group

Mean overall survival

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Model of Barr Fritcher et al for Evaluating a Patient with a Pancreatobiliary Stricture for the Risk of Malignancy
Clinical Diagnosis, Including Family History For Genetics
- Tata Memorial Hospital Scoring System (TMHSS) for Gallbladder Cancer
- Model of Barr Fritcher et al for Evaluating a Patient with a Pancreatobiliary Stricture for the Risk of Malignancy
Criteria For Diagnosis
- Tata Memorial Hospital Scoring System (TMHSS) for Gallbladder Cancer
Severity, Prognosis, Stage
- Tata Memorial Hospital Scoring System (TMHSS) for Gallbladder Cancer

Therapy

Options
- Tata Memorial Hospital Scoring System (TMHSS) for Gallbladder Cancer

Monitoring

Response To Therapy
- Tata Memorial Hospital Scoring System (TMHSS) for Gallbladder Cancer

Specialty

Hematology Oncology
Surgery, general
Gastroenterology

Objective

severity
prognosis
stage

ICD-10

C22.1 - Malignant neoplasm, intrahepatic bile duct carcinoma
C24 - Malignant neoplasm of other and unspecified parts of biliary tract

Info

Purpose: To evaluate a patient with advanced biliary tract adenocarcinoma using the prognostic index of Park et al.

Specialty: Hematology Oncology, Surgery, general, Gastroenterology

Objective: severity, prognosis, stage

ICD-10: C22.1, C24,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path